ATTR- and AFib amyloid - two different types of amyloid in the annular ligament of trigger finger

References

• Scharf H-P, Rüter A, Pohlemann T, et al. Orthopädie und Unfallchirurgie. 2nd. ed. Berlin: Elsevier; 2018.
   Google Scholar
• Jeanmonod R, Harberger S, Waseem M. Trigger finger. In StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Lee M, Jung YR, Lee YK. Trigger finger secondary to a neglected flexor tendon rupture. Medicine. 2019;98(1):e13980. doi: 10.1097/MD.0000000000013980
   PubMed Web of Science ®Google Scholar
• Buxbaum JN, Dispenzieri A, Eisenberg DS, et al. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid. 2022;29(4):213–219. doi: 10.1080/13506129.2022.2147636
   PubMed Web of Science ®Google Scholar
• Treitz C, Gottwald J, Gericke E, et al. Quantitative proteome profiling provides evidence of an activation of the complement Cascade in ATTR amyloidosis. Amyloid. 2022;29(2):102–109. doi: 10.1080/13506129.2021.2015316
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10(3):355–364. doi: 10.1177/10.3.355
   Web of Science ®Google Scholar
• Hahn K, Nilsson KPR, Hammarstrom P, et al. Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome. Amyloid. 2017;24(2):78–86. doi: 10.1080/13506129.2017.1316711
   PubMed Web of Science ®Google Scholar
• Gregorini G, Izzi C, Obici L, et al. Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol. 2005;16(12):3680–3686. doi: 10.1681/ASN.2005040382
   PubMed Web of Science ®Google Scholar
• Schönland SO, Hegenbart U, Bochtler T, et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood. 2012;119(2):488–493. doi: 10.1182/blood-2011-06-358507
   PubMed Web of Science ®Google Scholar
• Gioeva Z, Urban P, Meliss RR, et al. ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin. Amyloid. 2013;20(1):1–6. doi: 10.3109/13506129.2012.750604
   PubMed Web of Science ®Google Scholar
• Doellinger J, Schneider A, Hoeller M, et al. Sample preparation by easy extraction and digestion (SPEED) - a universal, rapid, and detergent-free protocol for proteomics based on acid extraction. Mol Cell Proteomics. 2020;19(1):209–222. doi: 10.1074/mcp.TIR119.001616
   PubMed Web of Science ®Google Scholar
• Tyanova S, Cox J. Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. In: von Stechow L, editor. Cancer systems biology: methods and protocols. New York, NY: Springer New York; 2018. p. 133–148.
   Google Scholar
• Vizcaino JA, Deutsch EW, Wang R, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–226. doi: 10.1038/nbt.2839
   PubMed Web of Science ®Google Scholar
• Gottwald J, Röcken C. The amyloid proteome: a systematic review and proposal of a protein classification system. Crit Rev Biochem Mol Biol. 2021;56(5):526–542. doi: 10.1080/10409238.2021.1937926
   PubMed Web of Science ®Google Scholar
• Wisniewski JR, Ostasiewicz P, Dus K, et al. Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol Syst Biol. 2012;8:611.
   PubMed Web of Science ®Google Scholar
• Varadi M, De Baets G, Vranken WF, et al. AmyPro: a database of proteins with validated amyloidogenic regions. Nucleic Acids Res. 2018;46(D1):D387–D392. doi: 10.1093/nar/gkx950
   PubMed Web of Science ®Google Scholar
• Helder MR, Schaff HV, Nishimura RA, et al. Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction. Am J Cardiol. 2014;114(9):1396–1399. doi: 10.1016/j.amjcard.2014.07.058
   PubMed Web of Science ®Google Scholar
• Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid. 2011;18(4):177–182. doi: 10.3109/13506129.2011.630762
   PubMed Web of Science ®Google Scholar
• Maleszewski JJ, Murray DL, Dispenzieri A, et al. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013;22(3):189–194. doi: 10.1016/j.carpath.2012.09.001
   PubMed Web of Science ®Google Scholar
• Rezania K, Pytel P, Smit LJ, et al. Systemic transthyretin amyloidosis in a patient with bent spine syndrome. Amyloid. 2013;20(2):131–134. doi: 10.3109/13506129.2013.792248
   PubMed Web of Science ®Google Scholar
• Garnier C, Briki F, Nedelec B, et al. VLITL is a major cross-beta-sheet signal for fibrinogen aalpha-chain frameshift variants. Blood. 2017;130(25):2799–2807. doi: 10.1182/blood-2017-07-796185
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Leung N, et al. Mass spectrometry-based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol. 2010;5(12):2180–2187. doi: 10.2215/CJN.02890310
   PubMed Web of Science ®Google Scholar
• Sethi S, Vrana JA, Theis JD, et al. Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int. 2012;82(2):226–234. doi: 10.1038/ki.2012.108
   PubMed Web of Science ®Google Scholar
• Sethi S, Vrana JA, Theis JD, et al. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens. 2013;22(3):273–280. doi: 10.1097/MNH.0b013e32835fe37c
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD. Pathology and diagnosis of renal non-AL amyloidosis. J Nephrol. 2018;31(3):343–350. doi: 10.1007/s40620-017-0426-6
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27–68. doi: 10.1146/annurev-biochem-061516-045115
   PubMed Web of Science ®Google Scholar
• Fosbol EL, Rorth R, Leicht BP, et al. Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes. J Am Coll Cardiol. 2019;74(1):15–23. doi: 10.1016/j.jacc.2019.04.054
   PubMed Web of Science ®Google Scholar
• Lauppe RE, Liseth Hansen J, Gerdeskold C, et al. Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden. Open Heart. 2021;8(2):e001755. doi: 10.1136/openhrt-2021-001755
   PubMed Web of Science ®Google Scholar
• Hahn K, Urban P, Meliss RR, et al. Carpal tunnel syndrome and ATTR-amyloidosis. Handchir Mikrochir Plast Chir. 2018;50(5):329–334.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Schönland S, Bergner R, et al. Three German fibrinogen alpha-chain amyloidosis patients with the p.Glu526Val mutation. Virchows Arch. 2008;453(1):25–31. doi: 10.1007/s00428-008-0619-4
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lachmann HJ, Rowczenio D, et al. Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen a alpha-chain amyloidosis. J Am Soc Nephrol. 2009;20(2):444–451. doi: 10.1681/ASN.2008060614
   PubMed Web of Science ®Google Scholar
• von Hutten H, Mihatsch M, Lobeck H, et al. Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol. 2009;33(8):1198–1205. doi: 10.1097/PAS.0b013e3181abdfa7
   PubMed Web of Science ®Google Scholar
• Picken MM. Fibrinogen amyloidosis: the clot thickens!. Blood. 2010;115(15):2985–2986. doi: 10.1182/blood-2009-12-236810
   PubMed Web of Science ®Google Scholar
• Chapman J, Dogan A. Fibrinogen alpha amyloidosis: insights from proteomics. Expert Rev Proteomics. 2019; Sep16(9):783–793. doi: 10.1080/14789450.2019.1659137
   PubMed Web of Science ®Google Scholar
• Hur WS, Flick MJ. Abeta peptide and fibrinogen weave a web of destruction in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A. 2020;117(27):15391–15393. doi: 10.1073/pnas.2009999117
   PubMed Web of Science ®Google Scholar
• Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer’s disease. J Exp Med. 2007;204(8):1999–2008. doi: 10.1084/jem.20070304
   PubMed Web of Science ®Google Scholar
• Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2017;37(3):e13–e21.
   PubMed Web of Science ®Google Scholar
• Page MJ, Thomson GJA, Nunes JM, et al. Serum amyloid a binds to fibrin(ogen), promoting fibrin amyloid formation. Sci Rep. 2019;9(1):3102. doi: 10.1038/s41598-019-39056-x
   PubMedGoogle Scholar